Bristol Myers Squibb Co (BMY) Goodwill & Intangibles (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Goodwill & Intangibles for 18 consecutive years, with $39.1 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Goodwill & Intangibles fell 9.33% year-over-year to $39.1 billion; the TTM figure through Jun 2026 stood at $39.1 billion (down 9.33% YoY), while the FY2025 annual figure was $40.9 billion, down 9.26% from the prior year.
• Goodwill & Intangibles eased to $39.1 billion in Q2 2026 per BMY's latest filing, from $40.0 billion in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $60.6 billion in Q1 2022 and bottomed at $39.1 billion in Q2 2026.
• Historically, Goodwill & Intangibles has averaged $49.4 billion across 5 years, with a median of $49.4 billion in 2023.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles retreated 0.43% — and 2025, when it fell 18.85%.
• Bristol Myers Squibb's Goodwill & Intangibles stood at $57.0 billion in 2022, then decreased by 15.38% to $48.2 billion in 2023, then dropped by 6.66% to $45.0 billion in 2024, then dropped by 9.26% to $40.9 billion in 2025, then fell by 4.23% to $39.1 billion in 2026.
• Business Quant data shows BMY's Goodwill & Intangibles at $39.1 billion in Q2 2026, $40.0 billion in Q1 2026, and $40.9 billion in Q4 2025.